Synopsis
Synopsis
0
EU WC
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Eqvalan
2. Ivermectin
3. Ivomec
4. Mectizan
5. Mk 933
6. Mk-933
7. Mk933
8. Stromectol
1. Ivermectin
2. Dihydroavermectin B1a
3. 70288-86-7
4. 22,23-dihydroavermectin B1a
5. 70161-11-4
6. Ivermectin Component B1a
7. 71827-03-7
8. Avermectin H2b1a
9. 5-o-demethyl-22,23-dihydroavermectin A1a
10. Chebi:63941
11. 91y2202ouw
12. (2ae,4e,5's,6s,6'r,7s,8e,11r,13r,15s,17ar,20r,20ar,20bs)-6'-[(2s)-butan-2-yl]-20,20b-dihydroxy-5',6,8,19-tetramethyl-17-oxo-3',4',5',6,6',10,11,14,15,17,17a,20,20a,20b-tetradecahydro-2h,7h-spiro[11,15-methanofuro[4,3,2-pq][2,6]benzodioxacyclooctadecine-13,2'-pyran]-7-yl 2,6-dideoxy-4-o-(2,6-dideoxy-3-o-methyl-alpha-l-arabino-hexopyranosyl)-3-o-methyl-alpha-l-arabino-hexopyranoside
13. Mk-933
14. (1r,4s,5's,6r,6'r,8r,10e,12s,13s,14e,16e,20r,21r,24s)-6'-[(2s)-butan-2-yl]-21,24-dihydroxy-12-[(2r,4s,5s,6s)-5-[(2s,4s,5s,6s)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-5',11,13,22-tetramethylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one
15. Ivermectin B1a-d2
16. C48h74o14
17. Unii-91y2202ouw
18. 22,23-dihydroavermectin B(1)a
19. Ncgc00163233-01
20. Ivermectin (ivm)
21. Ivm
22. Einecs 276-046-2
23. Dihydro Avermectin Bla
24. Brn 4643153
25. 22,23-dihydro-5-o-demethylavermectin A1a
26. H2b1a
27. Prestwick3_000156
28. Dsstox_cid_3181
29. Ivermectin (mk-0933)
30. Dsstox_rid_76909
31. Dsstox_gsid_23181
32. Bspbio_000292
33. Schembl312795
34. Bpbio1_000322
35. Chembl263291
36. Dtxsid8023181
37. Chebi:94551
38. Hms2089m09
39. Hms2095o14
40. Hms3712o14
41. Wca82703
42. Tox21_112034
43. Bdbm50409816
44. Mfcd30496678
45. S1351
46. Akos027470116
47. Ivermectin Component B1a [mi]
48. Zinc238808778
49. Zinc252286706
50. Ac-6014
51. Ccg-220156
52. Ncgc00186639-01
53. Ncgc00186639-03
54. As-14167
55. Bi166167
56. Cas-71827-03-7
57. Hy-126937
58. Ab00513813
59. Cs-0108408
60. 22,23-dihydroavermectin B1a; Ivermectin
61. Ab00513813-02
62. Ab00513813-03
63. Ab00513813_04
64. Avermectin A1a, 22,23-dihydro-5-o-demethyl-
65. 288i867
66. Ivermectin, Antibiotic For Culture Media Use Only
67. Q-201262
68. Brd-k24652731-001-02-7
69. Brd-k85554912-001-08-9
70. Q27132923
71. Ivermectin, British Pharmacopoeia (bp) Reference Standard
72. Ivermectin, European Pharmacopoeia (ep) Reference Standard
73. Ivermectin, United States Pharmacopeia (usp) Reference Standard
74. Ivermectin, Pharmaceutical Secondary Standard; Certified Reference Material
75. (2ae,4e,5's,6s,6'r,7s,8e,11r,13r,15s,17ar,20r,20ar,20bs)-6'-[(2s)-butan-2-yl]-20,20b-dihydroxy-5',6,8,19-tetramethyl-17
76. Clooctadecine-13,2'-pyran]-7-yl 2,6-dideoxy-4-o-(2,6-dideoxy-3-o-methyl-alpha-l-arabino-hexopyranosyl)-3-o-methyl-alpha-l-arabino-hexopyranoside
Molecular Weight | 875.1 g/mol |
---|---|
Molecular Formula | C48H74O14 |
XLogP3 | 4.1 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 14 |
Rotatable Bond Count | 8 |
Exact Mass | 874.50785703 g/mol |
Monoisotopic Mass | 874.50785703 g/mol |
Topological Polar Surface Area | 170 Ų |
Heavy Atom Count | 62 |
Formal Charge | 0 |
Complexity | 1680 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 20 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 3 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Treatment of rosacea
Antiparasitic Agents
Drugs used to treat or prevent parasitic infections. (See all compounds classified as Antiparasitic Agents.)
Insecticides
Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)
D - Dermatologicals
D11 - Other dermatological preparations
D11A - Other dermatological preparations
D11AX - Other dermatologicals
D11AX22 - Ivermectin
P - Antiparasitic products, insecticides and repellents
P02 - Anthelmintics
P02C - Antinematodal agents
P02CF - Avermectines
P02CF01 - Ivermectin
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17673
Submission : 2004-07-18
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-01-09
Pay. Date : 2012-12-14
DMF Number : 21395
Submission : 2008-03-05
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2022-04-06
Pay. Date : 2022-01-13
DMF Number : 36494
Submission : 2021-11-15
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2014-02-08
Pay. Date : 2012-12-18
DMF Number : 21624
Submission : 2008-05-08
Status : Active
Type : II
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13037
Submission : 1998-06-15
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 12755
Submission : 1997-11-21
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 38553
Submission : 2023-06-27
Status : Active
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Certificate Number : CEP 2021-382 - Rev 00
Status : Valid
Issue Date : 2024-08-02
Type : Chemical
Substance Number : 1336
Certificate Number : R0-CEP 2021-477 - Rev 00
Status : Valid
Issue Date : 2022-04-22
Type : Chemical
Substance Number : 1336
Certificate Number : R1-CEP 2008-104 - Rev 02
Status : Withdrawn by Holder
Issue Date : 2020-06-08
Type : Chemical
Substance Number : 1336
Certificate Number : R1-CEP 1998-138 - Rev 05
Status : Valid
Issue Date : 2020-02-28
Type : Chemical
Substance Number : 1336
Certificate Number : R1-CEP 2001-146 - Rev 01
Status : Valid
Issue Date : 2008-11-27
Type : Chemical
Substance Number : 1336
Certificate Number : R1-CEP 2004-070 - Rev 01
Status : Valid
Issue Date : 2011-08-02
Type : Chemical
Substance Number : 1336
Certificate Number : R0-CEP 2010-123 - Rev 00
Status : Expired
Issue Date : 2011-10-25
Type : Chemical
Substance Number : 1336
Certificate Number : R1-CEP 2001-077 - Rev 01
Status : Valid
Issue Date : 2017-10-16
Type : Chemical
Substance Number : 1336
Certificate Number : R0-CEP 2006-008 - Rev 01
Status : Expired
Issue Date : 2010-06-17
Type : Chemical
Substance Number : 1336
Certificate Number : CEP 1999-176 - Rev 06
Status : Valid
Issue Date : 2025-01-10
Type : Chemical
Substance Number : 1336
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 1%
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : India
Ivermectin; Praziquantel; Pyrantel Pamoate
Brand Name : Ivermectin|Praziquantel|Pyrantel
Dosage Form : Flavoured Tablet
Dosage Strength : 136MG; 114MG; 114MG
Packaging : 1*4
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name : Ivermectin|Clorsulon
Dosage Form : Injection
Dosage Strength : 10; 100
Packaging : 10 mL, 50 mL
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : South Korea
Brand Name : Antip
Dosage Form : Premix
Dosage Strength : 2G/KG
Packaging : 1KG, 5KG, 20KG
Approval Date :
Application Number :
Regulatory Info :
Registration Country : South Korea
Regulatory Info : RX
Registration Country : USA
Brand Name : IVERMECTIN
Dosage Form : TABLET;ORAL
Dosage Strength : 3MG
Packaging :
Approval Date : 2014-10-24
Application Number : 204154
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Canada
Brand Name : ROSIVER
Dosage Form : CREAM
Dosage Strength : 1%/W/W
Packaging : 15/30/45/60G
Approval Date :
Application Number : 2440342
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Uncoated Tablet
Dosage Strength : 12mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : Australia
Brand Name : Stromectol
Dosage Form : tablet
Dosage Strength : 3 mg
Packaging : 4
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Dispersible Tablet
Dosage Strength : 400MG; 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : China
Brand Name : Evermec
Dosage Form : Oral Solution/Suspension
Dosage Strength : 0.5%
Packaging : 500ML,1000ML
Approval Date :
Application Number :
Regulatory Info :
Registration Country : China
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Reply
04 Jul 2025
Reply
05 Apr 2025
Reply
28 Feb 2025
Reply
15 Oct 2024
Reply
27 Sep 2024
Reply
03 Jan 2024
Reply
03 Jul 2023
Reply
06 Jun 2023
Patents & EXCLUSIVITIES
Patent Expiration Date : 2034-03-13
US Patent Number : 9782425
Drug Substance Claim :
Drug Product Claim :
Application Number : 206255
Patent Use Code : U-1631
Delist Requested :
Patent Use Description : TREATMENT OF INFLAMMAT...
Patent Expiration Date : 2034-03-13
Patent Expiration Date : 2034-03-13
US Patent Number : 9233117
Drug Substance Claim :
Drug Product Claim :
Application Number : 206255
Patent Use Code : U-1631
Delist Requested :
Patent Use Description : TREATMENT OF INFLAMMAT...
Patent Expiration Date : 2034-03-13
Patent Expiration Date : 2034-03-13
US Patent Number : 9089587
Drug Substance Claim :
Drug Product Claim :
Application Number : 206255
Patent Use Code : U-1631
Delist Requested :
Patent Use Description : TREATMENT OF INFLAMMAT...
Patent Expiration Date : 2034-03-13
Patent Expiration Date : 2034-03-13
US Patent Number : 9233118
Drug Substance Claim :
Drug Product Claim :
Application Number : 206255
Patent Use Code : U-1631
Delist Requested :
Patent Use Description : TREATMENT OF INFLAMMAT...
Patent Expiration Date : 2034-03-13
Patent Expiration Date : 2034-03-13
US Patent Number : 10206939
Drug Substance Claim :
Drug Product Claim :
Application Number : 206255
Patent Use Code : U-1631
Delist Requested :
Patent Use Description : TREATMENT OF INFLAMMAT...
Patent Expiration Date : 2034-03-13
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
50
PharmaCompass offers a list of Ivermectin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ivermectin manufacturer or Ivermectin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ivermectin manufacturer or Ivermectin supplier.
PharmaCompass also assists you with knowing the Ivermectin API Price utilized in the formulation of products. Ivermectin API Price is not always fixed or binding as the Ivermectin Price is obtained through a variety of data sources. The Ivermectin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Ivomec manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ivomec, including repackagers and relabelers. The FDA regulates Ivomec manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ivomec API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ivomec manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ivomec supplier is an individual or a company that provides Ivomec active pharmaceutical ingredient (API) or Ivomec finished formulations upon request. The Ivomec suppliers may include Ivomec API manufacturers, exporters, distributors and traders.
click here to find a list of Ivomec suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Ivomec DMF (Drug Master File) is a document detailing the whole manufacturing process of Ivomec active pharmaceutical ingredient (API) in detail. Different forms of Ivomec DMFs exist exist since differing nations have different regulations, such as Ivomec USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Ivomec DMF submitted to regulatory agencies in the US is known as a USDMF. Ivomec USDMF includes data on Ivomec's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Ivomec USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Ivomec suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Ivomec Drug Master File in Japan (Ivomec JDMF) empowers Ivomec API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Ivomec JDMF during the approval evaluation for pharmaceutical products. At the time of Ivomec JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Ivomec suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Ivomec Drug Master File in Korea (Ivomec KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Ivomec. The MFDS reviews the Ivomec KDMF as part of the drug registration process and uses the information provided in the Ivomec KDMF to evaluate the safety and efficacy of the drug.
After submitting a Ivomec KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Ivomec API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Ivomec suppliers with KDMF on PharmaCompass.
A Ivomec CEP of the European Pharmacopoeia monograph is often referred to as a Ivomec Certificate of Suitability (COS). The purpose of a Ivomec CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Ivomec EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Ivomec to their clients by showing that a Ivomec CEP has been issued for it. The manufacturer submits a Ivomec CEP (COS) as part of the market authorization procedure, and it takes on the role of a Ivomec CEP holder for the record. Additionally, the data presented in the Ivomec CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Ivomec DMF.
A Ivomec CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Ivomec CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Ivomec suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Ivomec as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Ivomec API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Ivomec as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Ivomec and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Ivomec NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Ivomec suppliers with NDC on PharmaCompass.
Ivomec Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ivomec GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ivomec GMP manufacturer or Ivomec GMP API supplier for your needs.
A Ivomec CoA (Certificate of Analysis) is a formal document that attests to Ivomec's compliance with Ivomec specifications and serves as a tool for batch-level quality control.
Ivomec CoA mostly includes findings from lab analyses of a specific batch. For each Ivomec CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ivomec may be tested according to a variety of international standards, such as European Pharmacopoeia (Ivomec EP), Ivomec JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ivomec USP).